Stock price when the opinion was issued
EPS of 4c beat estimates of 1.2c; revenue of $225M beat estimates of $222M. Still, F2026 forecast was lowered: to sales $1.01B from estimates $1.03B. Margins to 78.5% from 79.3%. Q1 sales to $228M from $235.6M estimated. Most brokers re-iterated their ratings. It was a decent Q4, but a less-than-ideal forecast is always going to hit a stock trading at 105X earnings. We do not think it is a time for panic, and the company will see its first proft this fiscal year (ends January 31). But in this market, we think buyers can wait: we would give it a HOLD.
Unlock Premium - Try 5i Free
Not in the same league as CRWD based on market cap. But closest you can come to a CRWD product. He's not saying it will be an acquisition, but it will have challenges with scale, as everyone's knocking on their door. Buy here around $23, again around $20, and the final third around $18. 12-month price target of $25. Reports August 30. No dividend.
(Analysts’ price target is $25.47)